ATE280157T1 - 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii - Google Patents
4-aroyl-piperidin-ccr-3 rezeptor antagonisten iiiInfo
- Publication number
- ATE280157T1 ATE280157T1 AT99953974T AT99953974T ATE280157T1 AT E280157 T1 ATE280157 T1 AT E280157T1 AT 99953974 T AT99953974 T AT 99953974T AT 99953974 T AT99953974 T AT 99953974T AT E280157 T1 ATE280157 T1 AT E280157T1
- Authority
- AT
- Austria
- Prior art keywords
- ccr
- aroyl
- piperidine
- receptor antagonists
- iii
- Prior art date
Links
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10879698P | 1998-11-17 | 1998-11-17 | |
| PCT/EP1999/008548 WO2000029377A1 (en) | 1998-11-17 | 1999-11-08 | 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE280157T1 true ATE280157T1 (de) | 2004-11-15 |
Family
ID=22324087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99953974T ATE280157T1 (de) | 1998-11-17 | 1999-11-08 | 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6140344A (de) |
| EP (1) | EP1131291B1 (de) |
| JP (1) | JP3475177B2 (de) |
| KR (1) | KR20010087395A (de) |
| CN (1) | CN1163484C (de) |
| AR (1) | AR029150A1 (de) |
| AT (1) | ATE280157T1 (de) |
| AU (1) | AU757747B2 (de) |
| BR (1) | BR9915403A (de) |
| CA (1) | CA2350722A1 (de) |
| CO (1) | CO5150176A1 (de) |
| DE (2) | DE69921351T2 (de) |
| ES (2) | ES2230899T3 (de) |
| FR (1) | FR2785902B1 (de) |
| GB (1) | GB2343891B (de) |
| IT (1) | IT1307062B1 (de) |
| PE (1) | PE20001303A1 (de) |
| PT (1) | PT1131291E (de) |
| TR (1) | TR200101155T2 (de) |
| UY (1) | UY25804A1 (de) |
| WO (1) | WO2000029377A1 (de) |
| ZA (1) | ZA200103249B (de) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6605623B1 (en) | 1998-12-18 | 2003-08-12 | Bristol-Myers Squibb Pharma Co. | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| DE69926919D1 (de) | 1998-12-18 | 2005-09-29 | Bristol Myers Squibb Pharma Co | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren |
| EP1156807A4 (de) * | 1998-12-18 | 2002-04-03 | Du Pont Pharm Co | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren |
| CA2350730A1 (en) * | 1998-12-18 | 2000-06-22 | George V. Delucca | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| KR20010108394A (ko) | 1999-03-26 | 2001-12-07 | 다비드 에 질레스 | 신규 화합물 |
| GB0013060D0 (en) | 2000-05-31 | 2000-07-19 | Astrazeneca Ab | Chemical compounds |
| GB0017174D0 (en) * | 2000-07-12 | 2000-08-30 | Novartis Ag | Organic compounds |
| TWI227231B (en) * | 2000-07-12 | 2005-02-01 | Novartis Ag | 4-benzoyl-piperidine derivatives for treating conditions mediated by CCR-3 |
| GB0021670D0 (en) | 2000-09-04 | 2000-10-18 | Astrazeneca Ab | Chemical compounds |
| CA2423251A1 (en) | 2000-09-29 | 2002-04-04 | Glaxo Group Limited | Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| FR2821356A1 (fr) * | 2001-02-23 | 2002-08-30 | Cerep | Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations |
| GB0114699D0 (en) | 2001-06-15 | 2001-08-08 | Novartis Ag | Organic compounds |
| GB0117899D0 (en) | 2001-07-23 | 2001-09-12 | Astrazeneca Ab | Chemical compounds |
| SE0102809D0 (sv) * | 2001-08-22 | 2001-08-22 | Astrazeneca Ab | Novel compounds |
| TW200303304A (en) | 2002-02-18 | 2003-09-01 | Astrazeneca Ab | Chemical compounds |
| CN1753891A (zh) | 2003-02-27 | 2006-03-29 | 霍夫曼-拉罗奇有限公司 | Ccr－3受体拮抗剂 |
| JP4736043B2 (ja) | 2003-03-14 | 2011-07-27 | 小野薬品工業株式会社 | 含窒素複素環誘導体およびそれらを有効成分とする薬剤 |
| JP4710606B2 (ja) | 2003-04-18 | 2011-06-29 | 小野薬品工業株式会社 | スピロピペリジン化合物およびその医薬用途 |
| SG131946A1 (en) * | 2003-10-24 | 2007-05-28 | Hoffmann La Roche | Ccr3 receptor antagonists |
| SE0400208D0 (sv) | 2004-02-02 | 2004-02-02 | Astrazeneca Ab | Chemical compounds |
| KR101231466B1 (ko) | 2004-09-13 | 2013-02-07 | 오노 야꾸힝 고교 가부시키가이샤 | 질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는약제 |
| EP1889622A4 (de) | 2005-05-31 | 2009-12-23 | Ono Pharmaceutical Co | Spiropiperidinverbindung und deren medizinische verwendung |
| ES2427989T3 (es) | 2005-10-28 | 2013-11-05 | Ono Pharmaceutical Co., Ltd. | Compuesto que contiene un grupo básico y uso del mismo |
| WO2007058322A1 (ja) | 2005-11-18 | 2007-05-24 | Ono Pharmaceutical Co., Ltd. | 塩基性基を含有する化合物およびその用途 |
| JPWO2007105637A1 (ja) | 2006-03-10 | 2009-07-30 | 小野薬品工業株式会社 | 含窒素複素環誘導体およびそれらを有効成分とする薬剤 |
| WO2007132846A1 (ja) | 2006-05-16 | 2007-11-22 | Ono Pharmaceutical Co., Ltd. | 保護されていてもよい酸性基を含有する化合物およびその用途 |
| WO2008016006A1 (fr) | 2006-07-31 | 2008-02-07 | Ono Pharmaceutical Co., Ltd. | Composé auquel un groupe cyclique est lié par une liaison spiro et son utilisation |
| WO2010129351A1 (en) | 2009-04-28 | 2010-11-11 | Schepens Eye Research Institute | Method to identify and treat age-related macular degeneration |
| EP2787346B1 (de) | 2011-11-28 | 2017-06-21 | National University Corporation Nagoya University | Biomarker für lymphozytische infundibuloneurohypophysitis und seine verwendung |
| CN111050558B (zh) * | 2017-09-13 | 2022-05-27 | 先正达参股股份有限公司 | 杀微生物的喹啉(硫代)羧酰胺衍生物 |
| US11185074B2 (en) | 2017-09-13 | 2021-11-30 | Syngenta Participations Ag | Microbiocidal quinoline (thio)carboxamide derivatives |
| JP7202367B2 (ja) | 2017-09-13 | 2023-01-11 | シンジェンタ パーティシペーションズ アーゲー | 殺微生物性キノリン（チオ）カルボキサミド誘導体 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK159420C (da) * | 1983-03-09 | 1991-03-11 | Ciba Geigy Ag | N-(piperidinyl-alkyl)-carboxamider og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af antipsykotiske farmaceutiske praeparater |
| FI97540C (fi) * | 1989-11-06 | 1997-01-10 | Sanofi Sa | Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi |
| JPH041128A (ja) * | 1990-03-07 | 1992-01-06 | Ajinomoto Co Inc | 抗不整脈薬 |
| US5143923B1 (en) * | 1991-04-29 | 1993-11-02 | Hoechst-Roussel Pharmaceuticals Incorporated | Benzoisothiazole-and benzisoxazole-3-carboxamides |
| DK60893D0 (da) * | 1993-05-26 | 1993-05-26 | Novo Nordisk As | Piperidinderivater, deres fremstilling og anvendelse |
| WO1995000481A1 (en) * | 1993-06-23 | 1995-01-05 | Merrell Dow Pharmaceuticals Inc. | Piperidin-1-yl-2,2-dialkylpropanonearylsulfonamide derivatives |
| EP0661266A1 (de) * | 1993-12-27 | 1995-07-05 | Toa Eiyo Ltd. | Substituierte cyclische Aminverbindungen als 5HT2 Antagonisten |
| US5728835A (en) * | 1993-12-27 | 1998-03-17 | Toa Eiyo, Ltd. | Substituted cyclic amine compound, production process thereof and pharmaceutical composition for circulatory organ use containing the same |
| JPH09249566A (ja) * | 1996-03-19 | 1997-09-22 | Takeda Chem Ind Ltd | ピペリジン化合物含有ケモカイン受容体拮抗剤 |
| DE19624659A1 (de) * | 1996-06-20 | 1998-01-08 | Klinge Co Chem Pharm Fab | Neue Pyridylalken- und Pyridylalkinsäureamide |
| CZ425598A3 (cs) * | 1996-06-27 | 1999-08-11 | Smithkline Beecham Corporation | Antagonista IL-8 receptoru |
| US6323206B1 (en) * | 1996-07-12 | 2001-11-27 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| WO1999004794A1 (en) * | 1997-07-25 | 1999-02-04 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
| IL125658A0 (en) * | 1997-08-18 | 1999-04-11 | Hoffmann La Roche | Ccr-3 receptor antagonists |
| AU2335699A (en) * | 1998-01-21 | 1999-08-09 | Kyowa Hakko Kogyo Co. Ltd. | Chemokine receptor antagonists and methods of use therefor |
-
1999
- 1999-11-08 AT AT99953974T patent/ATE280157T1/de not_active IP Right Cessation
- 1999-11-08 CA CA002350722A patent/CA2350722A1/en not_active Abandoned
- 1999-11-08 ES ES99953974T patent/ES2230899T3/es not_active Expired - Lifetime
- 1999-11-08 WO PCT/EP1999/008548 patent/WO2000029377A1/en not_active Ceased
- 1999-11-08 AU AU10459/00A patent/AU757747B2/en not_active Ceased
- 1999-11-08 CN CNB998131784A patent/CN1163484C/zh not_active Expired - Fee Related
- 1999-11-08 PT PT99953974T patent/PT1131291E/pt unknown
- 1999-11-08 DE DE69921351T patent/DE69921351T2/de not_active Expired - Fee Related
- 1999-11-08 EP EP99953974A patent/EP1131291B1/de not_active Expired - Lifetime
- 1999-11-08 BR BR9915403-0A patent/BR9915403A/pt not_active IP Right Cessation
- 1999-11-08 TR TR2001/01155T patent/TR200101155T2/xx unknown
- 1999-11-08 KR KR1020017006070A patent/KR20010087395A/ko not_active Ceased
- 1999-11-08 JP JP2000582364A patent/JP3475177B2/ja not_active Expired - Fee Related
- 1999-11-12 PE PE1999001151A patent/PE20001303A1/es not_active Application Discontinuation
- 1999-11-15 GB GB9926969A patent/GB2343891B/en not_active Expired - Fee Related
- 1999-11-15 FR FR9914276A patent/FR2785902B1/fr not_active Expired - Fee Related
- 1999-11-15 AR ARP990105788A patent/AR029150A1/es unknown
- 1999-11-16 ES ES009902495A patent/ES2160525B1/es not_active Expired - Fee Related
- 1999-11-16 UY UY25804A patent/UY25804A1/es unknown
- 1999-11-16 IT IT1999TO000990A patent/IT1307062B1/it active
- 1999-11-16 CO CO99071853A patent/CO5150176A1/es unknown
- 1999-11-17 DE DE19955340A patent/DE19955340A1/de not_active Withdrawn
- 1999-11-17 US US09/441,919 patent/US6140344A/en not_active Expired - Fee Related
-
2001
- 2001-04-20 ZA ZA200103249A patent/ZA200103249B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB2343891A (en) | 2000-05-24 |
| IT1307062B1 (it) | 2001-10-23 |
| KR20010087395A (ko) | 2001-09-15 |
| TR200101155T2 (tr) | 2001-09-21 |
| WO2000029377A1 (en) | 2000-05-25 |
| FR2785902A1 (fr) | 2000-05-19 |
| PE20001303A1 (es) | 2000-11-30 |
| CA2350722A1 (en) | 2000-05-25 |
| US6140344A (en) | 2000-10-31 |
| DE69921351D1 (de) | 2004-11-25 |
| BR9915403A (pt) | 2001-08-14 |
| ITTO990990A1 (it) | 2001-05-16 |
| CN1326441A (zh) | 2001-12-12 |
| DE69921351T2 (de) | 2006-03-09 |
| ITTO990990A0 (it) | 1999-11-16 |
| AR029150A1 (es) | 2003-06-18 |
| PT1131291E (pt) | 2005-01-31 |
| GB9926969D0 (en) | 2000-01-12 |
| GB2343891B (en) | 2001-05-30 |
| ES2160525B1 (es) | 2002-06-16 |
| CN1163484C (zh) | 2004-08-25 |
| JP3475177B2 (ja) | 2003-12-08 |
| DE19955340A1 (de) | 2000-05-31 |
| ZA200103249B (en) | 2002-07-22 |
| AU1045900A (en) | 2000-06-05 |
| FR2785902B1 (fr) | 2003-09-26 |
| UY25804A1 (es) | 2001-07-31 |
| CO5150176A1 (es) | 2002-04-29 |
| ES2160525A1 (es) | 2001-11-01 |
| AU757747B2 (en) | 2003-03-06 |
| JP2002529531A (ja) | 2002-09-10 |
| EP1131291B1 (de) | 2004-10-20 |
| ES2230899T3 (es) | 2005-05-01 |
| EP1131291A1 (de) | 2001-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69921351D1 (de) | 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii | |
| DE69812096D1 (de) | Neuropeptid y rezeptorantagonisten | |
| NO20012411D0 (no) | Pyrrolidin-derivater-CCR-3-reseptorantagonister | |
| IS5706A (is) | Adenosín A3 viðtakastillar | |
| DE69734833D1 (de) | Vitronektin rezeptor antagonisten | |
| NO20001100D0 (no) | IL-8 reseptorantagonister | |
| NO993586L (no) | K-8 reseptor antagonister | |
| DK1009732T3 (da) | 1-Amino-alkylcyclohexan NMDA receptor antagonister | |
| CY2010003I1 (el) | Αγωνιστες των βητα-2 αδρενεργικων υποδοχεων | |
| ATE232200T1 (de) | Neuropeptid y5-rezeptorantagonisten | |
| EP0986385A4 (de) | Antagonisten des gonadorelins | |
| ID24726A (id) | Antagonis-antagonis reseptor trombin | |
| DE69919171D1 (de) | Muskarin-rezeptor antagonisten | |
| ID26223A (id) | Antagonis reseptor vitronektin | |
| ID24162A (id) | Antagonis-antagonis reseptor vitronektin | |
| DE69838874D1 (de) | Il-8 rezeptor-antagonisten | |
| ID28811A (id) | Antagonis reseptor vitronektin | |
| DE69831413T2 (de) | Il-8 rezeptor antagonisten | |
| DE69824837D1 (de) | Il-8-rezeptor-antagonisten | |
| NO20010620D0 (no) | Vitronektinreseptor-antagonister | |
| ID22978A (id) | Antagonis reseptor endotelin | |
| NO20010353D0 (no) | IL-8 reseptor-antagonist | |
| EP0957908A4 (de) | Antagonisten des fibrinogen rezeptors | |
| TR199601082A3 (tr) | Entegrin reseptör antagonistleri. | |
| DK1131291T3 (da) | 4-aroyl-piperidin-CCR-3-receptorantagonister III |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1131291 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |